We are live on ! Find out more
MG

Michael Gelband ExodusPoint Capital Management

AUM $15.5B
1-Year Est. Return 38.81%
 

Michael Gelband is a co-founder of ExodusPoint Capital Management, a multi-strategy hedge fund launched by veterans of larger alternative platforms. The firm pursues diversified strategies across asset classes with a focus on risk-managed absolute returns. Gelband’s firm is followed as part of the newer generation of multi-strategy complexes.

This Fund
S&P 500
This Quarter Est. Return
+10.63%
1 Year Est. Return
+38.81%
3 Year Est. Return
+110.53%
5 Year Est. Return
+124.16%
10 Year Est. Return
AUM
$15.2B
AUM Growth
+$4.78B
Cap. Flow
+$3.57B
Cap. Flow %
23.39%
Top 10 Hldgs %
44.86%
Holding
2,187
New
553
Increased
436
Reduced
404
Closed
789

Top Sells

Rank Stock Value
1
VMW
VMware, Inc
VMW
+$95.7M
2
QQQ icon
Invesco QQQ Trust
QQQ
+$89.4M
3
XOM icon
ExxonMobil
XOM
+$84.7M
4
SO icon
Southern Company
SO
+$79.2M
5
EMR icon
Emerson Electric
EMR
+$61.3M

Sector Composition

Rank Sector Weight
1 Technology 9.26%
2 Industrials 7.84%
3 Utilities 7.6%
4 Healthcare 5.4%
5 Real Estate 4.62%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ORGO icon
1901
Organogenesis Holdings
ORGO
$232M
-123,737
Closed -$393K
ORLY icon
1902
O'Reilly Automotive
ORLY
$72.1B
-319,680
Closed -$19.4M
OSIS icon
1903
OSI Systems
OSIS
$3.41B
-10,642
Closed -$1.26M
OTIS icon
1904
Otis Worldwide
OTIS
$27.2B
-106,785
Closed -$8.58M
OXY icon
1905
Occidental Petroleum
OXY
$61.3B
-209,318
Closed -$13.6M
PANW icon
1906
Palo Alto Networks
PANW
$292B
-30,256
Closed -$4.05M
PARR icon
1907
Par Pacific Holdings
PARR
$3.96B
-61,701
Closed -$2.22M
PAYC icon
1908
Paycom
PAYC
$10.3B
-13,449
Closed -$3.49M
PBH icon
1909
Prestige Consumer Healthcare
PBH
$2.43B
-27,644
Closed -$1.58M
PBI icon
1910
Pitney Bowes
PBI
$2.26B
-16,830
Closed -$51K
PCRX icon
1911
Pacira BioSciences
PCRX
$983M
-14,707
Closed -$451K
PCTY icon
1912
Paylocity
PCTY
$8.14B
-18,391
Closed -$3.34M
PDFS icon
1913
PDF Solutions
PDFS
$1.93B
-66,447
Closed -$2.15M
PEG icon
1914
Public Service Enterprise Group
PEG
$36.2B
-54,903
Closed -$3.13M
PENN icon
1915
PENN Entertainment
PENN
$2.5B
-197,092
Closed -$4.52M
PFE icon
1916
Pfizer
PFE
$160B
-1,261,820
Closed -$41.9M
PFGC icon
1917
Performance Food Group
PFGC
$16.5B
-36,005
Closed -$2.12M
PFSI icon
1918
PennyMac Financial
PFSI
$3.9B
-3,246
Closed -$216K
PGNY icon
1919
Progyny
PGNY
$1.97B
-95,874
Closed -$3.26M
PHAT icon
1920
Phathom Pharmaceuticals
PHAT
$718M
-17,008
Closed -$176K
PHM icon
1921
Pultegroup
PHM
$24.6B
-6,670
Closed -$494K
PII icon
1922
Polaris
PII
$3.66B
-25,648
Closed -$2.67M
PIII icon
1923
P3 Health Partners
PIII
$40.3M
-270
Closed -$20K
PIPR icon
1924
Piper Sandler
PIPR
$5.3B
-22,324
Closed -$811K
PLL
1925
DELISTED
Piedmont Lithium
PLL
-9,464
Closed -$376K

Similar funds

Michael Gelband's Q4 2023 Portfolio in Review

As of Q4 2023, Michael Gelband held 2,187 positions worth $15.2B, up 46% from $10.5B the previous quarter. Its ten largest holdings account for 45% of the portfolio.

Michael Gelband deployed $3.57B of net new capital in Q4 2023, opening 553 new positions and adding to 436 existing holdings. Its largest new stake was Fidelity National Information Services: 6,650,397 shares worth $399M.

By sector, the portfolio is most concentrated in Technology at 9.3% of assets, down from 10% a quarter earlier, followed by Industrials and Utilities.

On the sell side, the largest reduction was Merck, an estimated $48.2M trimmed.

  • Michael Gelband's largest Q4 2023 buy was Fidelity National Information Services: 6,650,397 shares worth $399M.
  • Michael Gelband added most to Global Payments in Q4 2023, an estimated $250M increase.
  • Michael Gelband's biggest Q4 2023 reduction was Merck, cutting an estimated $48.2M.
  • Michael Gelband fully exited VMware, Inc in Q4 2023, selling an estimated $95.7M.
  • Michael Gelband's ten largest holdings make up 45% of its $15.2B portfolio in Q4 2023.
  • Michael Gelband opened 553 new positions and closed 789 in Q4 2023.
  • Michael Gelband's portfolio value rose 46% quarter-over-quarter to $15.2B.

Based on ExodusPoint Capital Management's 13F filing for Q4 2023, filed 14 Feb 2024.